-
- Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study. Kumar SK; Lee JH; Lahuerta JJ; Morgan G; Richardson PG; Crowley J; Haessler J; Feather J; Hoering A; Moreau P; LeLeu X; Hulin C; Klein SK; Sonneveld P; Siegel D; Bladé J; Goldschmidt H; Jagannath S; Miguel JS; Orlowski R; Palumbo A; Sezer O; Rajkumar SV; Durie BG Leukemia 26: 149-157. FI: 9,561 (Q1) (D1) Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation Sanchez-Guijo, Fermin M.; Lopez-Villar, Olga; Lopez-Anglada, Lucia; Villaron, Eva M.; Muntion, Sandra; Diez-Campelo, Maria; Perez-Simon, Jose A.; San Miguel, Jesus F.; Caballero, Dolores; del Canizo, Maria-Consuelo. Transfusion. 52: 1086-1091. FI: 3,217 (Q2) (D4) CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotyp Paíno T; Ocio EM; Paiva B; San-Segundo L; Garayoa M; Gutiérrez NC; Sarasquete ME; Pandiella A; Orfao A; San Miguel JF. Haematologica-The Hematology Journal. 97: 1110-1114. FI: 6,424 (Q1) Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients Paiva, B.; Gutierrez, N-C; Chen, X.; Vidriales, M-B; Montalban, M-A; Rosinol, L.; Oriol, A.; Martinez-Lopez, J.; Mateos, M-V; Lopez-Corral, L.; Diaz-Rodriguez, E.; Perez, J-J; Fernandez-Redondo, E.; de Arriba, F.; Palomera, L.; Bengoechea, E.; Terol, M-J; de Paz, R.; Martin, A.; Hernandez, J.; Orfao, A.; Lahuerta, J-J; Blade, J.; Pandiella, A.; San Miguel, J-F; GEM Cooperative Study Grp; PETHEMA Cooperative Study Grp Leukemia 26: 1862-1869. FI: 9,561 (Q1) (D1) Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Santamaria, Carlos; Hernandez-Campo, Pilar; Blanco, Juan F.; Sanchez-Guijo, Fermin M.; Hernandez-Iglesias, Teresa; Brinon, Jesus G.; Fisac-Herrero, Rosa M.; Lee, Francis Y.; Pandiella, Atanasio; Garayoa, Mercedes Plos One. 7. FI: 4,092 (Q1) (D2) Effects of MSC-co-administration and route of delivery on cord blood hematopoietic stem cell engraftment Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; Miguel JF; Cañizo MC; Sanchez-Guijo FM. Cell Transplantation FI: 6,204 (Q1) (D1) Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment. Gutierrez-Cosio, S.; de la Rica, L.; Ballestar, E.; Santamaria, C.; Sanchez-Abarca, L. I.; Caballero-Velazquez, T.; Blanco, B.; Calderon, C.; Herrero-Sanchez, C.; Carrancio, S.; Ciudad, L.; Canizo, C.; San Miguel, J. F.; Perez-Simon, J. A.. Leukemia Research. 36: 895-899. FI: 2,923 (Q2) (D4) European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses Ludwig H; Avet-Loiseau H; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Davies F; de la Rubia J; Delimpasi S; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Hess U; Mellqvist UH; Moreau P; San-Miguel J; Sondergeld P; Sonneveld P; Udvardy M; Palumbo A. Oncologist 17: 592-606. FI: 3,812 (Q2) (D3) Evaluation of prognostic factors among patients with chronic graft-versus-host disease Perez-Simon, Jose A.; Afram, Gabriel; Martino, Rodrigo; Pinana, Jose L.; Caballero-Velazquez, Teresa; Ringden, Olle; Valcarcel, David; Caballero, Dolores; Remberger, Mats; de Paz, Yanira; Sierra, Jordi; San Miguel, Jesus; Hagglund, Hans Haematologica-The Hematology Journal. 97: 1187-1195. FI: 6,424 (Q1) (D1) Genomic analysis of high-risk smoldering multiple myeloma Lopez-Corral, Lucia; Victoria Mateos, Maria; Corchete, Luis A.; Eugenia Sarasquete, Maria; de la Rubia, Javier; de Arriba, Felipe; Lahuerta, Juan-Jose; Garcia-Sanz, Ramon; San Miguel, Jesus F.; Gutierrez, Norma C.. Haematologica-The Hematology Journal. 97: 1439-1443. FI: 6,424 (Q1) (D1)
|
